299. Cystic fibrosis
1,592 clinical trials,   1,539 drugs   (DrugBank: 255 drugs),   81 drug target genes,   162 drug target pathways

Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00803179
(ClinicalTrials.gov)
November 20084/12/2008Growth Hormone Therapy for Wasting in Cystic FibrosisGrowth Hormone Therapy for Wasting in Cystic FibrosisCystic FibrosisDrug: Nutropin AQUniversity of Massachusetts, WorcesterNULLTerminated18 YearsN/AAll5Phase 1United States
2NCT00079742
(ClinicalTrials.gov)
September 200311/3/2004A Study to Evaluate Nutropin AQ for the Treatment of Growth Restriction in Children With Cystic FibrosisA Phase II, Multicenter, Randomized, Controlled, Open-Label Study of the Safety and Efficacy of Nutropin AQ [Somatropin (DNA Origin) Injection] for the Treatment of Growth Restriction in Children With Cystic FibrosisCystic FibrosisDrug: Nutropin AQ [somatropin (DNA origin) injection]Genentech, Inc.NULLCompleted5 Years13 YearsBoth68Phase 2United States
3NCT00256555
(ClinicalTrials.gov)
February 200017/11/2005Growth Hormone Treatment Study in Children With Cystic FibrosisGROWTH HORMONE USE IN CYSTIC FIBROSIS - A MULTICENTER STUDYCystic FibrosisDrug: Nutropin AQUniversity of Texas Southwestern Medical CenterGenentech, Inc.Withdrawn5 Years12 YearsAll0Phase 2;Phase 3NULL